Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO)

CUSIP: 984015602

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 6 signals
Share change
+40,685
SEC-reported price per share
$4.00
Indexed holders
13
Value change
+$160,445
Number of buys
5
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,342,128

Security key

984015602

Report period

Q4 2024

Indexed institutions

13

Top holders

10

Ownership snapshot

Top reported holders of XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sachetta, LLC
Disclosed value leader
Sachetta, LLC
Comparable rows
0/14
Latest evidence
30 Sep 2024
13F 3/4/5 Highest disclosed value: $75,043 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

Sachetta, LLC has the largest disclosed position value at $75K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sachetta, LLC's linked filing trail.
Disclosed position value Top 5
Sachetta, LLC $75K
RENAISSANCE TECHNOLOGIES LLC $68.5K
GEODE CAPITAL MANAGEMENT, LLC $52.1K
JTC Employer Solutions Trustee Ltd $12K
Tower Research Capital LLC (TRC) $3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sachetta, LLC
13F
Company
13F
—
denominator unverified
$75,043
17,371 shares
— 30 Sep 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$68,472
15,850 shares
— 30 Sep 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$52,102
11,889 shares
— 30 Sep 2024
JTC Employer Solutions Trustee Ltd
13F
Company
13F
—
denominator unverified
$12,000
2,700 shares
— 30 Sep 2024
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$2,989
692 shares
— 30 Sep 2024
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$876
200 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
13
Shares
89,449
Indexed holders
13
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 indexed holders
9
Q4 2024 indexed holders
13
Indexed holder difference
4
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .